Peripheral Blood and Pleural Fluid Mononuclear Cell Responses to Low-Molecular-Mass Secretory Polypeptides of Mycobacterium tuberculosis in Human Models of Immunity to Tuberculosis

A total of 104 polypeptides were purified from the low-molecular-mass secretory proteome of Mycobacterium tuberculosis H₃₇Rv using a combination of anion exchange column chromatography and high resolution preparative sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by electroelutio...

Full description

Saved in:
Bibliographic Details
Published inInfection and Immunity Vol. 73; no. 6; pp. 3547 - 3558
Main Authors Sable, Suraj B, Kumar, Rajnish, Kalra, Mamta, Verma, Indu, Khuller, G. K, Dobos, Karen, Belisle, John T
Format Journal Article
LanguageEnglish
Published Washington, DC American Society for Microbiology 01.06.2005
Subjects
Online AccessGet full text
ISSN0019-9567
1098-5522
DOI10.1128/IAI.73.6.3547-3558.2005

Cover

Loading…
More Information
Summary:A total of 104 polypeptides were purified from the low-molecular-mass secretory proteome of Mycobacterium tuberculosis H₃₇Rv using a combination of anion exchange column chromatography and high resolution preparative sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by electroelution. The goal of this study was to identify polypeptides from a low-molecular-mass secretory proteome recognized by human subjects infected with M. tuberculosis and to ascertain the differences in specificity of antigen recognition by the peripheral blood mononuclear cells (PBMCs) and pleural fluid mononuclear cells (PFMCs) of these individuals. The study identified CFP-8 (Rv0496), CFP-11 (Rv2433c), CFP-14.5 (Rv2445c), and CFP-31 (Rv0831c) as novel T-cell antigens apart from previously characterized ESAT-6, TB10.4, CFP10, GroES, MTSP14, MTSP17, CFP21, MPT64, Ag85A, and Ag85B on the basis of recognition by PBMCs of tuberculosis contacts and treated tuberculosis patients. Further, polypeptides prominently recognized by PFMCs of tuberculous pleurisy patients were the same as those recognized by PBMCs of healthy contacts and treated tuberculosis patients. The results of our study indicate the homogeneity of antigenic target recognition by lymphocytes at the site of infection and at the periphery in the human subjects studied and the need to evaluate these antigenic targets as components of future antituberculous vaccines.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Editor: J. L. Flynn
Corresponding author. Mailing address: Department of Biochemistry, PGIMER, Chandigarh, 160 012 India. Phone: 91 172 2747 585, ext. 5174. Fax: 91 172 2744 401. E-mail: gkkhuller@yahoo.co.in.
ISSN:0019-9567
1098-5522
DOI:10.1128/IAI.73.6.3547-3558.2005